使用末端执行器机器人设备评估单侧脑瘫儿童上肢功能的可行性研究
结果显示系统对使用者和临床医生均可行,机器人参数与临床评分呈中度至强相关(r范围0.375–0.643),提示可提供互补的定量信息。
要点
- MOTORE机器人系统在单侧脑瘫儿童评估中具有可行性,用户和临床医生反馈积极。
- HFCS或MACS水平及肢体严重程度是影响机器人表现的主要因素,年龄影响部分参数,手优势无显著影响。
- 机器人参数与临床评分呈中度至强相关(r=0.375–0.643),可作为补充定量信息。
核心结论
- MOTORE机器人系统在儿童评估环境中对用户和临床医生均可行。
- 观察到的关联提示该系统可能提供与上肢功能相关的补充定量信息。
- 研究为探索性,需进一步研究确立效度、信度和反应度后方可临床整合。
研究设计与样本
- 单次会话方案包括临床评估(MACS、HFCS、MA2、BBT)、MOTORE机器人评估(健侧与患侧)及可行性问卷。
- 采用MANOVA分析机器人参数,以肢体条件、手优势和年龄为预测因素,HFCS或MACS水平分别建模;Spearman相关分析临床与机器人指标关联。
主要发现
- 可行性问卷结果积极,支持系统的用户友好设计。
- MANOVA显示HFCS或MACS水平及肢体严重程度(患侧 vs 健侧)是影响机器人表现的主要因素。
- 年龄影响部分机器人参数,手优势无显著影响。
- 机器人参数与临床评分呈中度至强相关(r范围0.375–0.643)。
关键数值与推荐
- 临床评估包括MACS、HFCS、MA2和BBT。
- 机器人评估使用MOTORE平面末端执行器设备,分别评估健侧和患侧。
- 可行性数据以原始分数(均值、标准差、范围)和百分比分析。
临床怎么用
- MOTORE机器人系统可作为单侧脑瘫儿童上肢功能评估的可行工具,提供定量补充信息。
- 临床解读需结合HFCS或MACS水平及肢体严重程度,年龄可能影响部分参数。
- 目前尚不能替代标准化临床量表,需进一步验证效度、信度和反应度。
局限性
- 单次会话评估,未报告重测信度或纵向数据。
- 手优势无显著影响,但年龄仅影响部分参数,机制未明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Children with Unilateral Cerebral Palsy (UCP) are characterized by significant upper limbs (ULs) impairment that hinders daily activities and participation, requiring accurate assessment. Although motor impairment mainly affects one side, significant evidence suggests that the less affected side (LAS) may also present impairments. Considering the growing interest in pediatrics technologies, a complementary approach combining standardized clinical scales and robotic devices may support a more objective and quantitative evaluation of ULs performance with high precision and objectivity. This study aimed to investigate the feasibility of a planar end-effector robotic device in children and adolescents with UCP and to explore whether robotic ULs indices show associations with clinical measures. METHODS: Twenty-eight children and adolescents with UCP (mean ages: 10.90 ± 3.32 years; 8 males, 20 females) underwent a single-session protocol comprising: (i) clinical assessment based on ULs classifications - Manual Ability Classification System (MACS), House Functional Classification System (HFCS) - and clinical standardized scales - Melbourne Assessment 2 (MA2), Box and Block Test (BBT) -; (ii) robotic assessment protocol with MOTORE with more and less affected side (MAS and LAS respectively), and (iii) feasibility questionnaires completed by both children and clinicians to evaluate usability and acceptability. Feasibility data were analysed as raw scores (mean value, SD, range) and percentages. Two different MANOVA analyses were applied to robotic parameters, including limb condition (LAS vs. MAS), hand dominance, and age as predictors, with HFCS or MACS levels analysed in separate models to avoid conceptual overlap and collinearity. Finally, Spearman’s r correlation coefficient assessed correlations between clinical and robotic measures. RESULTS: Feasibility questionnaires showed positive results, supporting the system’s user-feasible design. Across the MOTORE tasks, MANOVA analyses showed that HFCS or MACS levels and limb severity condition (MAS vs. LAS) were the main factors affecting robotic performance, with age influencing selected parameters, while hand dominance had no significant effect. Finally, correlation analyses further revealed moderate to strong associations between MOTORE’s robotic parameters and clinical scores (r range: 0.375–0.643). CONCLUSIONS: This paper highlights the feasibility of MOTORE robotic system in pediatric assessment setting both for users and clinicians. The observed associations suggest that the system may provide complementary quantitative information related to ULs functions. As these findings are exploratory, further studies are required to establish validity, reliability, and responsiveness before clinical integration of the system to support objective and quantitative data to guide individualized rehabilitation strategies for children with UCP. Trial registration: ClinicalTrial.gov: NCT06012617 and NCT06666829.
引用
- Barzacchi V, Beani E, Filogna S, et al. Feasibility study of the assessment of upper limb function in children with Unilateral Cerebral Palsy using an end-effector robotic device. J Neuroeng Rehabil. 2026. PMID: 41857735. doi:10.1186/s12984-026-01950-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。